Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 14, 2025 • 4:30 AM ET

Date/Time Source News Release
05/08/2025 09:25 AM EDT GlobeNewswire Veru Participates in a Virtual Investor KOL Connect Segment
05/08/2025 06:30 AM EDT GlobeNewswire Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
05/01/2025 08:30 AM EDT GlobeNewswire Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
04/16/2025 08:30 AM EDT GlobeNewswire Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
03/31/2025 08:30 AM EDT GlobeNewswire Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
02/13/2025 06:30 AM EST GlobeNewswire Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
02/06/2025 08:30 AM EST GlobeNewswire Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
02/04/2025 08:30 AM EST GlobeNewswire Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/27/2025 06:30 AM EST GlobeNewswire Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction
12/31/2024 08:30 AM EST GlobeNewswire Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
Page

Additional News

As of May 14, 2025 • 4:30 AM ET

Date/Time Source News Release
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.